Anthera Pharma (ANTH) Files $100M Mixed Shelf
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Nanosphere (NSPH) Commences Common Stock Offering, Prelim. Q3 Revs Top Expectations
- Galena Biopharma (GALE) Files 2M Common Shelf for Shareholder
- Oncolytics Biotech (ONCY) Reports Amendment to Common Share Purchase Agreement with Lincoln Park
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!